D2b and d2a, d3, d4 corrected.Please note: fda registration number should be (b)(6) the reported event could not be confirmed, since the device was not returned for evaluation and no other evidence was provided.Nail breakage in general has been experienced but does not present an unanticipated event in itself.Depending on load application, also, depending on the patient¿s post implant behaviour and depending on suitable anatomical reduction, depending on the kind of bone breakage, depending on the course of bone healing and other factors ¿ e.G.Increased postoperative activities ¿ a nail breakage can rather be classified as anticipated; specifically if one or more contributing issues concurrence with each other.Initially ¿¿the nail was put in 2 months ago to fix a femur fracture that never healed properly.A non-union¿¿ and thus, it could not be excluded that the case is rather clinical conditions related.According to event description ¿¿the doctor's initial plan for the knee fusion was changed once we noticed that the nail was broken.¿¿ and finally, the broken nail was revised by a ¿larger t-2 alpha nail and titanium plate¿ which could be considered as a hint to insufficient bone healing.One requirement for successful nail treatment is a timely bone healing in order to relieve the nail over the progressing time of implantation.Potential adverse effects are clearly pointed out in the labelling.Nevertheless, more detailed information about the complaint event as well as the affected device must be available in order to determine the exact root cause of the complaint event.A review of the device history was not possible because the lot number was not communicated.No corrective actions are required at this time.An indication of material, manufacturing or design related problems could not be checked as the device was not made available for a physical evaluation.In case substantive information will become available in future that suggests otherwise we reserve the right to reopen the case.
|